Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Zydus Lifesciences Says Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement

BRIEF-Zydus Lifesciences Says Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement

- Zydus Lifesciences Ltd ZYDU.NS:

  • ZYDUS LIFESCIENCES - SENTYNL THERAPEUTICS AND MEREO BIOPHARMA ANNOUNCE OPTION AND LICENSE AGREEMENT

  • ZYDUS LIFESCIENCES - AGREEMENT FOR ALVELESTAT IN ALPHA-1 ANTITRYPSIN DEFICIENCYASSOCIATED LUNG DISEASE

  • ZYDUS LIFESCIENCES - SENTYNL GRANTED GLOBAL MANUFACTURING RIGHTS FOR ALVELESTAT AS PART OF AGREEMENT

Source text: ID:nnAZN4TDA4M

Further company coverage: ZYDU.NS


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zydus Lifesciences

See all news